Vegfc-expressing cells form heterotopic bone after musculoskeletal injury

Cell Rep. 2024 Apr 23;43(4):114049. doi: 10.1016/j.celrep.2024.114049. Epub 2024 Apr 3.

Abstract

Heterotopic ossification (HO) is a challenging condition that occurs after musculoskeletal injury and is characterized by the formation of bone in non-skeletal tissues. While the effect of HO on blood vessels is well established, little is known about its impact on lymphatic vessels. Here, we use a mouse model of traumatic HO to investigate the relationship between HO and lymphatic vessels. We show that injury triggers lymphangiogenesis at the injury site, which is associated with elevated vascular endothelial growth factor C (VEGF-C) levels. Through single-cell transcriptomic analyses, we identify mesenchymal progenitor cells and tenocytes as sources of Vegfc. We demonstrate by lineage tracing that Vegfc-expressing cells undergo osteochondral differentiation and contribute to the formation of HO. Last, we show that Vegfc haploinsufficiency results in a nearly 50% reduction in lymphangiogenesis and HO formation. These findings shed light on the complex mechanisms underlying HO formation and its impact on lymphatic vessels.

Keywords: CP: Cell biology; CP: Developmental biology; MPCs; Vegfc, VEGFC; heterotopic ossification; lymphangiogenesis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cell Differentiation
  • Disease Models, Animal
  • Haploinsufficiency
  • Lymphangiogenesis*
  • Lymphatic Vessels / metabolism
  • Lymphatic Vessels / pathology
  • Male
  • Mesenchymal Stem Cells* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Ossification, Heterotopic* / genetics
  • Ossification, Heterotopic* / metabolism
  • Ossification, Heterotopic* / pathology
  • Osteogenesis
  • Tenocytes / metabolism
  • Vascular Endothelial Growth Factor C* / genetics
  • Vascular Endothelial Growth Factor C* / metabolism

Substances

  • Vascular Endothelial Growth Factor C
  • vascular endothelial growth factor C, mouse